Used in research settings as a selective antagonist for the dopamine D3 receptor, aiding in the study of neurological pathways related to addiction, schizophrenia, and Parkinson’s disease. Shows potential in preclinical studies for modulating reward-seeking behavior and improving cognitive function in models of psychiatric disorders. Also employed as a tool compound to investigate receptor subtype specificity in neuropharmacology.